Literature DB >> 26322671

Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated Tuberculosis.

Clare L van Halsema1, Katherine L Fielding, Violet N Chihota, Elizabeth C George, James J Lewis, Gavin J Churchyard, Alison D Grant.   

Abstract

Clinical features of tuberculosis influence infectiousness. This cross-sectional study examined the effect of combination antiretroviral therapy (cART) and CD4 on sputum smear-positivity (SS+) and pulmonary cavitation among 1589 (1185/1589 HIV-positive) miners in South Africa. Proportions SS+ varied nonlinearly by CD4 with greatest proportions SS+ (55.3%) in the lowest stratum (<100 cells/μL). Adjusted prevalence ratio for SS+; on vs. off cART was 0.90 (95% confidence interval: 0.73 to 1.11). Proportions with cavitation varied linearly with CD4, with no independent cART effect (adjusted prevalence ratio 1.17; 95% confidence interval: 0.80 to 1.71). cART did not independently affect SS+ or cavitation but may increase infectiousness through CD4 recovery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26322671     DOI: 10.1097/QAI.0000000000000684

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

Review 1.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

Review 2.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

3.  Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?

Authors:  P Y Khan; A C Crampin; T Mzembe; O Koole; K L Fielding; K Kranzer; J R Glynn
Journal:  Int J Tuberc Lung Dis       Date:  2017-11-01       Impact factor: 2.373

4.  Space-time clustering of recently-diagnosed tuberculosis and impact of ART scale-up: Evidence from an HIV hyper-endemic rural South African population.

Authors:  Andrew Tomita; Catherine M Smith; Richard J Lessells; Alexander Pym; Alison D Grant; Tulio de Oliveira; Frank Tanser
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

Review 5.  Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.

Authors:  Peter S Nyasulu; Emery Ngasama; Jacques L Tamuzi; Lovemore N Sigwadhi; Lovelyn U Ozougwu; Ruvimbo B C Nhandara; Birhanu T Ayele; Teye Umanah; Jabulani Ncayiyana
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.